Phase II study of Bevacizumab in combination with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer.
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2011
At a glance
- Drugs Bevacizumab; Capecitabine; Docetaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 07 Jun 2011 New trial record